Lunai Bioworks Inc. Cash
Lunai Bioworks Inc. (LNAI) had Cash of $20.66 million as of 2021-06-30, per its 10-K filed 2021-09-24.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2021-09-24
- 2021-06-30: Cash $20.66M.
- 2020-06-30: Cash $8.70M.
- 2019-06-30: Cash $12.28M.
- 2014-12-31: Cash $3.01M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2021-06-30 | $20.66M 10-K · filed 2021-09-24 | |
| 2020-06-30 | $8.70M 10-K · filed 2021-09-24 | |
| 2019-06-30 | $12.28M 10-K · filed 2020-09-23 | |
| 2014-12-31 | $3.01M 10-K · filed 2015-03-31 | |
| 2014-09-30 | $597.74K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $181.02K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $54.47K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $18.79K 10-K · filed 2015-03-31 | $22.00 10-Q · filed 2014-02-11 |
| 2013-06-30 | $32.26K 10-Q · filed 2014-08-14 | $219.00 10-Q · filed 2013-08-15 |
| 2013-03-31 | $7.67K 10-Q · filed 2014-05-14 | $6.74K 10-K · filed 2013-07-16 |
| 2012-12-31 | $4.38K 10-Q · filed 2014-08-14 | $158.00 10-Q · filed 2013-02-14 |
| 2012-09-30 | $2.30K 10-Q · filed 2013-11-15 | |
| 2012-06-30 | $336.00 10-Q · filed 2013-08-15 | |
| 2012-03-31 | $336.00 10-Q · filed 2014-08-14 | |
| 2011-12-31 | $250.98K 10-Q · filed 2014-08-14 | $123.00 10-Q · filed 2012-02-21 |
| 2011-09-30 | $12.49K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $803.00 10-Q · filed 2012-08-20 | |
| 2011-03-31 | $0.00 10-K · filed 2012-07-17 | |
| 2011-01-17 | $0.00 10-K · filed 2012-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |